How Peptide Hormones Are Made, Released, and Detected

Many endocrine and neuroendocrine cells package processed peptides in secretory granules. A stimulus raises intracellular signaling, promotes granule fusion, and releases stored material into extracellular space or circulation. This architecture supports rapid, sometimes pulsatile output even though gene expression and peptide synthesis take longer. Measured concentration depends on sampling time, biological rhythm, clearance, assay specificity, and whether the method recognizes precursor, mature peptide, fragments, or several forms together.

Because peptides generally do not cross lipid membranes freely, many act through cell-surface receptors, including G protein-coupled receptors and receptor kinases. Ligand binding changes receptor conformation or assembly and initiates intracellular networks such as cyclic AMP, calcium, kinase, or phosphatase pathways. Receptor abundance, coupling proteins, feedback, and desensitization shape the response, so the same circulating peptide does not produce an identical effect in every tissue.

The category 'peptide hormone' describes a signaling role, not one molecular size, receptor family, or physiological function. Reliable records identify the human gene or precursor, mature chain boundaries, post-translational modifications, receptor, producing tissue, and evidence type. A synthetic analogue may share a pharmacophore while differing in sequence or kinetics, and should not be described as identical to the endogenous hormone. This page maps biology and does not support personal-use decisions.